Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Andreas Eugen Busch, PhD
Age : 55
Linked companies : Shire PLC
Summary 
Currently, Andreas Eugen Busch occupies the position of Chief Scientific Officer of Shire Plc. Dr. Busch is also on the board of Max-Delbrück-Centrum für Molekulare Medizin (MDC) and Head-Global Drug Discovery at Bayer Pharma AG and Head-Global Drug Discovery at Bayer HealthCare AG.

Dr. Busch previously was Head-Cardiovascular Research at Aventis Pharma AG, Head-Cardiovascular Research at Hoechst Marion Roussel, Inc. and Professor at Johann Wolfgang Goethe-Universität Frankfurt am Main.

Andreas Eugen Busch received a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main.


Current positions of Andreas Eugen Busch, PhD 
NameTitle Since
Shire PLC
(Pharmaceuticals)
Chief Scientific Officer 2018
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Member-Supervisory Board -
Bayer HealthCare AG Head-Global Drug Discovery 2005
Bayer Pharma AG Head-Global Drug Discovery 2007


Andreas Eugen Busch, PhD: Personal Network 
NameLinked companies
Gunnar Riemann Bayer Pharma AG
Bayer HealthCare AG
Richard Pott Bayer Pharma AG
Bayer HealthCare AG
Flemming Ørnskov Shire PLC
Bayer HealthCare AG
Bayer Pharma AG
Werner Baumann Bayer HealthCare AG
Bayer Pharma AG
Hubertus Erlen Bayer Pharma AG
Horst Domdey Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Ian Stuart Charles Talmage Bayer Pharma AG
Oliver Renner Bayer Pharma AG
Kerstin Crusius Bayer Pharma AG
Willy Beumann Bayer Pharma AG


Most Read News 
07/17BRIAN MOYNIHAN : Bank of America trims net interest income guidance
RE
07/15PATRICK THOMAS : Prologis to Buy Warehouse Owner Industrial Property Trust -- Update
DJ
07/18PATRICK THOMAS : Arabesque S-Ray Gets $20 Million Co-Investment
DJ
07/19CHARLES SCHWAB : Stocks That Defined The Week
DJ
07/16PETER THIEL : Trump Signals Scrutiny of Google's Ties With China After Thiel Comments
DJ
07/15BERNARD ARNAULT : LVMH pairs with Stella McCartney, igniting fashion rivalries
RE
07/17ELON MUSK : Top Company News of the Day
DJ
07/18MASAYOSHI SON : SoftBank's Son says Japan lacks investment opportunities, is AI 'developing country'
RE
07/16XAVIER ROLET : CQS looking to grow U.S. presence under new CEO Rolet
RE
07/19ROSS MCEWAN : Australia's NAB turns to RBS turnaround man Ross McEwan as CEO
RE
More news


© 2019 People and Ownership :   
Advertisement
Andreas Eugen Busch, PhD : Connections 
Freudenberg & Co. KG
Biotechnology Innovation Organization
Swiss-American Chamber of Commerce
Bayer Chemicals AG
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Pharmaceutical Research & Manufacturers of America
BioM AG Munich BioTech Development
Freudenberg SE
SCHOTT AG
Bayer Innovation GmbH
Covestro Deutschland AG
Currenta Geschäftsführungs GmbH
Verband der Chemischen Industrie eV
Freudenberg Group



Popular Business Leaders 
Paul Achleitner William Ackman Bernard Arnault Luciano Benetton Jeff Bezos Thierry Bolloré Olivier Brandicourt Richard Branson Warren Buffett Tim Cook Benjamin De Rothschild Leonardo Del Vecchio Herbert Diess Patrick Drahi John Edwards John Elkann Pierre Fabre Bill Gates Carlos Ghosn Terry Gou Philip Green Carl Icahn Daniel Loeb Jean-bernard Lévy Jack Ma Ross Mcewan Lakshmi Mittal Dennis Muilenburg Elon Musk Jean-charles Naouri Xavier Niel Nelson Peltz Philippe Petitcolin Hasso Plattner Alexandre Ricard Wilbur Ross Ann Sarnoff Eric Schmidt Charles Schwab Jean-dominique Senard Ulrich Spiesshofer Friede Springer Bernard Tapie Johannes Teyssen Patrick Thomas François Villeroy De Galhau John Williamson Steve Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders